Fusion Antibodies plc (FAB.L)
GBp 6.55
(0.77%)
GBp 6.55
(0.77%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.13 Million | 2.9 Million | 4.79 Million | 4.16 Million | 3.89 Million | 2.18 Million |
| Cost of Revenue | 1.4 Million | 2.69 Million | 3.08 Million | 2.85 Million | 2.74 Million | 1.37 Million |
| Gross Profit | -265 Thousand | 202 Thousand | 1.71 Million | 1.31 Million | 1.15 Million | 804 Thousand |
| Operating Expenses | 2.02 Million | 3.03 Million | 3.04 Million | 2.68 Million | 2.26 Million | 2.31 Million |
| Selling, General and Administrative Expenses | 1.77 Million | 2.22 Million | 2.35 Million | 2.07 Million | 1.87 Million | 2.39 Million |
| Research and Development Expenses | 254 Thousand | 806 Thousand | 699 Thousand | 613 Thousand | 391 Thousand | 240 Thousand |
| Other Expenses | -4000.00 | - | - | - | - | -86.4 Thousand |
| Cost and Expenses | 3.42 Million | 5.73 Million | 6.13 Million | 5.54 Million | 5 Million | 3.69 Million |
| Operating Income | -2.28 Million | -2.83 Million | -1.33 Million | -1.37 Million | -1.11 Million | -1.5 Million |
| Interest Expense | 5000.00 | 4000.00 | 9000.00 | 18 Thousand | 20 Thousand | 4033.00 |
| Income Tax Expense | -63 Thousand | -263 Thousand | -133 Thousand | 1.63 Million | -376 Thousand | -235.48 Thousand |
| Earnings before Tax | -2.28 Million | -2.85 Million | -1.33 Million | -1.26 Million | -1.07 Million | -1.49 Million |
| Net Income | -2.22 Million | -2.59 Million | -1.2 Million | -2.89 Million | -697 Thousand | -1.26 Million |
| Earnings Per Share Basic | -0.04 | -0.10 | -0.05 | -0.11 | -0.03 | -0.06 |
| Earnings Per Share Diluted | -0.04 | -0.10 | -0.05 | -0.11 | -0.03 | -0.06 |
| Weighted Average Shares Outstanding | 55.55 Million | 26.01 Million | 25.94 Million | 25.45 Million | 22.09 Million | 22.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.55 Million | 26.01 Million | 25.94 Million | 25.45 Million | 22.09 Million | 22.09 Million |
| Gross Margin | -0.23 | 0.07 | 0.36 | 0.31 | 0.30 | 0.37 |
| EBIT Margin | -1.82 | -0.85 | -0.12 | -0.16 | -0.13 | -0.49 |
| Profit Margin | -1.96 | -0.89 | -0.25 | -0.70 | -0.18 | -0.58 |
| EBITDA | -2.06 Million | -2.48 Million | -573 Thousand | -532 Thousand | -431 Thousand | -1.06 Million |
| Earnings Before Tax Margin | -2.01 | -0.98 | -0.28 | -0.33 | -0.29 | -0.69 |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.13 Million | 595 Thousand | 541 Thousand | 1.03 Million | 2.9 Million | 1.86 Million |
| Cost of Revenue | 1.4 Million | 651 Thousand | 750 Thousand | 1.19 Million | 2.69 Million | 1.5 Million |
| Gross Profit | -265 Thousand | -56 Thousand | -209 Thousand | -157 Thousand | 202 Thousand | 359 Thousand |
| Operating Expenses | 2.02 Million | 817 Thousand | 1.21 Million | 1.44 Million | 3.03 Million | 1.62 Million |
| Selling, General and Administrative Expenses | - | 745 Thousand | 1.02 Million | 1.09 Million | - | 1.17 Million |
| Research and Development Expenses | - | 72 Thousand | 182 Thousand | 354 Thousand | - | 452 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 3.42 Million | 1.46 Million | 1.96 Million | 2.64 Million | 5.73 Million | 3.12 Million |
| Operating Income | -2.29 Million | -873 Thousand | -1.41 Million | -1.6 Million | -2.83 Million | -1.26 Million |
| Interest Expense | 5000.00 | 2000.00 | 3000.00 | - | 4000.00 | 7000.00 |
| Income Tax Expense | -63 Thousand | - | -63 Thousand | -117 Thousand | -263 Thousand | -146 Thousand |
| Earnings before Tax | -2.28 Million | -869 Thousand | -1.42 Million | -1.59 Million | -2.85 Million | -1.26 Million |
| Net Income | -2.22 Million | -869 Thousand | -1.35 Million | -1.48 Million | -2.59 Million | -1.11 Million |
| Earnings Per Share Basic | - | -0.02 | -0.03 | -0.06 | - | -0.04 |
| Earnings Per Share Diluted | - | -0.02 | -0.03 | -0.06 | - | -0.04 |
| Weighted Average Shares Outstanding | 55.55 Million | 51.02 Million | 46.49 Million | 26.01 Million | 26.01 Million | 26.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.55 Million | 51.02 Million | 46.49 Million | 26.01 Million | 26.01 Million | 26.01 Million |
| Gross Margin | -0.23 | -0.09 | -0.39 | -0.15 | 0.07 | 0.19 |
| EBIT Margin | - | -1.31 | -2.39 | -1.43 | - | -0.55 |
| Profit Margin | -1.96 | -1.46 | -2.51 | -1.43 | -0.89 | -0.60 |
| EBITDA | - | -778 Thousand | -1.29 Million | -1.48 Million | - | -1.01 Million |
| Earnings Before Tax Margin | -2.02 | -1.47 | -2.62 | -1.55 | -0.98 | -0.68 |
CPX
0R1E
NILI
0906
600622
SCGL